New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
09:07 EDTGIII, SOL, HALO, EXEL, AI, VTNR, ARIA, SONC, HIMX, RAX, GOOG, LUXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Sonic (SONC), up 6.8%... Vertex Energy (VTNR), up 13%. ALSO HIGHER: Rackspace (RAX), up 5% following upgrade at Morgan Stanley... ReneSola (SOL), up 3.4% after upgraded at Roth Capital... Luxottica (LUX), up 3.7% after WSJ says the company is collaborating with Google (GOOG) on new versions of Google Glass... ARIAD (ARIA), up 4% following upgrade to Buy at H.C. Wainwright... Exelixis (EXEL), up 7% after COMETRIQ approved by European Commission... Halozyme (HALO), up 5% after meeting primary endpoint of HTI-501 clinical trial. DOWN AFTER EARNINGS: G-III Apparel (GIII), down 8.4%. ALSO LOWER: Arlington Asset (AI), down 3.7% after filing to sell 2.75M common shares... Himax Technologies (HIMX), down 6% after downgraded at BofA/Merrill.
News For LUX;GOOG;RAX;HIMX;SONC;ARIA;VTNR;AI;EXEL;HALO;SOL;GIII From The Last 14 Days
Check below for free stories on LUX;GOOG;RAX;HIMX;SONC;ARIA;VTNR;AI;EXEL;HALO;SOL;GIII the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 15, 2014
09:12 EDTRAXRackspace introduces new service-based pricing model
Subscribe for More Information
07:15 EDTGOOG, LUXIIR Holdings to hold a conference
14th Annual Shopper Insights in Action Conference to be held in Chicago on July 14-16.
06:15 EDTGOOGGoogle Fit may benefit remote medical care industry, DigiTimes Research says
Subscribe for More Information
06:02 EDTGOOGSamsung, Nest, ARM team up for Thread wireless networking protocol
Subscribe for More Information
05:44 EDTGOOGNovartis to license Google 'smart lens' technology
Novartis (NVS) announced that its eye care division Alcon has entered into an agreement with a division of Google (GOOG) to in-license its "smart lens" technology for all ocular medical uses. The agreement with Google[x], a team within Google that is devoted to finding new solutions to big global problems, provides Alcon with the opportunity to develop and commercialize Google's "smart lens" technology with the potential to transform eye care and further enhance Alcon's pipeline and global leadership in contact lenses and intraocular lenses. The transaction remains subject to anti-trust approvals. The agreement between Google and Alcon represents an important step for Novartis, across all of its divisions, to leverage technology to manage human diseases and conditions. Google's key advances in the miniaturization of electronics complement Novartis's deep pharmaceuticals and medical device expertise. Novartis aims to enhance the ways in which diseases are mapped within the body and ultimately prevented.
July 14, 2014
18:49 EDTGOOGGoogle initiated with an Outperform at FBR Capital
Subscribe for More Information
16:00 EDTGOOGOptions Update; July 14, 2014
Subscribe for More Information
11:20 EDTEXELExelixis seen as potential target for Roche, TheStreet says
Subscribe for More Information
10:15 EDTGOOGAmazon hires Google Glass creator Babak Parviz, TechCrunch reports
Subscribe for More Information
10:00 EDTRAXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:25 EDTGOOGGoogle looked to Page, Brin to woo Facebook workers, WSJ says
Subscribe for More Information
09:16 EDTEXELOn The Fly: Pre-market Movers
HIGHER: Citigroup (C), up 3.6% after reporting better than expected Q2 results, announcing $7B settlement with DOJ and FDIC... Apple (AAPL), up 0.7% after Barclays upgrades stock to Overweight, Morgan Stanley raises Apple estimates above consensus... Shire (SHPG), up 1.6% after receiving revised proposal from AbbVie (ABBV) of GPB 53.20 per share, which it says it would be willing to recommend to Shire shareholders. AbbVie is down 2.8% after the news... Mylan (MYL), up 4% after acquiring Abbott's (ABT) non-U.S. developed markets specialty and branded generics business in all-stock transaction valued at about $5.3B. Abbott up 1.6% after the news... Progenics (PGNX), up 13% after FDA says RELISTOR can be approved on data submitted in sNDA... Exelixis (EXEL), up 13% after announcing coBRIM Phase 3 trial met primary endpoint... URS (URS) up 8% after acquired by AECOM Technology (ACM) for $56.31 per share. AECOM shares alos up 2% after deal announcement... Whiting Petroleum (WLL), up 4.5% after agreeing to acquire Kodiak Oil & Gas (KOG) in a $6B transaction. Kodiak Oil & Gas up 3%... Kandi Technologies (KNDI), up 11% after announcing JV's sale of 4,114 EVs in Q2. LOWER: Riverbed (RVBD), down 4.5% after saying it sees its Q2 adjusted EPS at low end of 26c-28c range... Harmonic (HLIT), down 13% after reporting preliminary Q2 earnings results.. EBay (EBAY), down 0.5% after downgraded at Pacific Crest, confirming partnership plans with Sotheby's (BID).
08:18 EDTRAXRackspace upgraded to Neutral from Underperform at DA Davidson
Subscribe for More Information
08:10 EDTGOOGEndurance announces extension of partnership with Google
Endurance International Group (EIGI) announced the extension of its partnership with Google (GOOG) for the Get Your Business Online initiative. The partnership will allow more businesses to benefit from the overall web presence solutions the program provides. The Get Your Business Online program has already provided web presence services and support to bring hundreds of thousands of American businesses online for the first time.
07:37 EDTARIAARIAD announces continuation of Iclusig review under Article 20 procedure
ARIAD Pharmaceuticals announced that the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has provided the company with a request for limited additional information regarding Iclusig as part of its ongoing review under the Article 20 referral procedure. The PRAC has requested further information regarding proposed dose modifications after achievement of a response and patient monitoring and details concerning a risk management plan. Following ARIAD’s response and input from the agency’s Scientific Advisory Group, the company expects that the PRAC will complete its review and make final recommendations to the Committee for Medicinal Products for Human Use at its meeting in October. As we finalize our recommendations on dose modifications of Iclusig and response monitoring of patients, we will work closely with the European regulatory agency and its expert advisors so that CML patients and their treating physicians have the best guidance available supporting the appropriate use of Iclusig,” said Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer at ARIAD. In March ARIAD submitted responses to initial questions outlined by the PRAC as part of the Article 20 process, which was initiated in December of last year, and responses to a second set of questions were submitted to the PRAC in June.
06:10 EDTGOOGTaiwan touch panel makers see more orders from handset vendors, DigiTimes says
Subscribe for More Information
06:10 EDTSOLReneSola files $150M mixed securities shelf
Subscribe for More Information
05:19 EDTEXELExelixis announces coBRIM Phase 3 trial met primary endpoint
Subscribe for More Information
July 13, 2014
17:00 EDTGOOGYouTube mulls funding production to add premium content, Reuters says
Subscribe for More Information
July 12, 2014
15:59 EDTGOOGGoogle expands in San Francisco, San Jose Mercury News says
Google is building out its presence in San Francisco by leasing space in one location and buying an office tower on the Embarcadero, says San Jose Mercury News. Reference Link
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use